$284.08
-48.21-14.51%
Last update: Nov 2, 1:03 PM
Krystal Biotech Inc
KRYSNASDAQ
Krystal Biotech (KRYS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.90 | $1.89 | $1.43 | $1.61 |
| Actual | $2.05 | $1.79 | $1.83 | $1.70 |
| Surprise | +7.89% | -5.29% | +28.0% | +5.59% |
| Revenue | ||||
| Estimate | $126.2M | $122.8M | $112.1M | $106.5M |
| Actual | $127.3M | $119.2M | $116.4M | $107.1M |
| Surprise | +0.93% | -2.95% | +3.76% | +0.55% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $1.99 | $2.48 | $2.14 |
| Revenue | |||
| Consensus | $133.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $2.05 | $1.90 | 7.89 % |
| Q2 | Aug 3, 2026 | $1.79 | $1.89 | -5.29 % |
| Q1 | May 4, 2026 | $1.83 | $1.43 | 28.0 % |
| Q4 | Feb 17, 2026 | $1.70 | $1.61 | 5.59 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $127.34M | $126.16M | 0.93 % |
| Q2 | Aug 3, 2026 | $119.22M | $122.85M | -2.95 % |
| Q1 | May 4, 2026 | $116.36M | $112.14M | 3.76 % |
| Q4 | Feb 17, 2026 | $107.11M | $106.52M | 0.55 % |
